Organizational reputation and jurisdictional claims: The case of the U.S. food and drug administration

Governance

Volumn 23, Issue 1, 2010, Pages 133-159

  Maor, Moshe ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 73449096432     PISSN: 09521895     EISSN: 14680491     Source Type: Journal    
DOI: 10.1111/j.1468-0491.2009.01470.x     Document Type: Article

References (65)

1. Bardoel, Jo Leen d'Haenens. 2004 Media Meet the Citizen: Beyond Market Mechanisms and Government Regulations European Journal of Communication 19 (2 165 194.
2. Baughman, John. 2006. Common Ground: Committee Politics in the U.S. House of Representatives. Stanford, CA : Stanford University Press.
3. Berg, Paul, David Baltimore, Herbet W. Boyer, Stanley N. Cohen, Ronald W. Davis, David S. Hogness, Richard Roblin, James D. Watson, Sherman Weismman Norton D. Zinder. 1974 Potential Biohazard of Recombinant DNA Molecules Science 185 : 303.
4. Boehmke, Frederick J., Sean Gailmard John Wiggs Patty. 2005 Whose Ear to Bend? Information Sources and Venue Choice in Policy Making Quarterly Journal of Political Science 1 (September 139 169.
5. Campbell, Angela. 2005 Ethos and Economics: Examining the Rationale Underlying Stem Cell and Cloning Research Policies in the United States, Germany and Japan American Journal of Law and Medicine 31 (1 47 143.
6. Cannon, Robert. 2005 State Regulatory Approaches to VoIP: Policy, Implementation, and Outcome Federal Communication Law Journal 57 (3 479 510.
7. Carpenter, Daniel P. 2001. The Forging of Bureaucratic Autonomy: Reputations, Networks, and Policy Innovation in Executive Agencies, 1862-1928. Princeton, NJ : Princeton University Press.
8. Carpenter, Daniel P. 2002 Groups, the Media, Agency Waiting Costs, and FDA Drug Approval American Journal of Political Science 46 (July 490 505.
9. Carpenter, Daniel P. 2004a The Political Economy of FDA Drug Review: Processing, Politics, and Lessons for Policy Health Affairs 23 (1 52 63.
10. Carpenter, Daniel P. 2004b Protection without Capture: Product Approval by a Politically Responsive Learning Regulator American Political Science Review 98 (4 613 631.
11. Cox, Gary W. Mathew D. McCubbins. 1993. Legislative Leviathan: Party Government in the House. Berkeley, CA : University of California Press.
12. Croley, Steven P. 2008. Regulation and Public Interests: The Possibility of Good Regulatory Governance. Princeton, NJ : Princeton University Press.
13. Culliton, Barbara J. 1985 Gene Therapy: Research in Public Science 227 (4686 493 496.
14. Curwen, Peter. 1999 Television without Frontier - Can Culture Be Harmonized European Business Review 99 (6 368 375.
15. Feintuck, Mike. 2004 The Public Interest" in Regulation. Oxford, UK : Oxford University Press.
16. Fredrickson, Donald S. 2001. The Recombinant DNA Controversy: A Memoir, Science, Politics, and the Public Interest 1974-1981. Herndon, VA : ASM Press.
17. Greene, Adam. 2001 The World after Dolly: International Regulation of Human Cloning George Washington International Law Review 3392 : 341 362.
18. Grossman, Lewis A., Richard A. Merrill Peter Barton Hutt. 2008 FDA Jurisdiction: A Matter of Definition Washington College of Law Research Paper No. 2008-38. 〈 http://ssrn.com/abstract1097623 〉. (November 13, 2009).
19. Heimann, C. F. Larry. 1997. Acceptable Risks: Politics, Policy and Risky Technologies. Ann Arbor, MI : University of Michigan Press.
20. Horning Priest, Susanna. 2001 Cloning: A Study in News Production Public Understanding of Science 10 : 59 69.
21. Huang, Anny. 1998 FDA Regulation of Genetic Testing: Institutional Reluctance and Public Guardianship Food and Drug Law Journal 53 : 554 591.
22. Huber, John D. Nolan McCarty. 2004 Bureaucratic Capacity, Delegation, and Political Reform American Political Science Review 98 (3 481 495.
23. Indech, Barbara. 2000 The International Harmonization of Human Tissue Regulation: Regulatory Control over Human Tissue Use and Tissue Banking in Select Countries and the Current State of International Harmonization Efforts Food and Drug Law Journal 5 : 343 372.
24. Javitt, Gail H. 2007 In Vitro Diagnostic Multivariate Index Assays Public Meeting; Docket No. 2006D-0347. Comments on behalf of the Genetic and Public Policy Center, February 8.
25. Javitt, Gail H. Kathy Hudson. 2003 Regulating (for the Benefit of) Future Persons: A Different Perspective on the FDA's Jurisdiction to Regulate Human Reproductive Cloning Utah Law Review 4 : 1201 1229.
26. Kahan, Jonathan. 1995 FDA Regulation of Human Tissue for Transplantation Clinical Supplement July : 1.
27. Kessler, David A. 2001. A Question of Intent: A Great American Battle with a Deadly Industry. New York : Public Affairs Books.
28. Krause, George A. James W. Douglas. 2005 Institutional Design versus Reputational Effects on Bureaucratic Performance: Evidence from U.S. Government Macroeconomic and Fiscal Projections Journal of Public Administration Research and Theory 15 (January 281 306.
29. Lyon, Jeff Peter Gorner. 1996. Altered Fates: Gene Therapy and the Retooling of Human Life. New York : W.W. Norton & Company.
30. Maor, Moshe. 2007 A Scientific Standard and an Agency's Legal Independence: Which of These Reputation-Protection Mechanisms Is Less Susceptible to Political Moves Public Administration 85 (4 961 978.
31. Maor, Moshe. 2009 Organizational Reputations and the Observability of Public Warnings in 10 Pharmaceutical Markets Working Paper, The Hebrew University of Jerusalem.
32. Maor, Moshe Raanan Sulitzeanu-Kenan. 2009 Knowing, Acting and Reputation: An Analysis of the Duration of FDA's Decisions to Issue Warning Letters Working Paper, The Hebrew University of Jerusalem.
33. Merrill, Richard A. 1996 The Architecture of Government Regulation of Medical Product Virginia Law Review 82 (8 1753 1866.
34. Merrill, Richard A. 2002 Human Tissue and Reproductive Cloning: New Technologies Challenge FDA Houston Journal of Health Law and Policy 3 (1 1 82.
35. Merrill, Richard A. Bryan Rose. 2001 FDA Regulation of Human Cloning: Usurpation or Statesmanship Harvard Journal of Law and Technology 15 (1 85 150.
36. Merrill, Richard A. Gail H. Javitt. 2000 Gene Therapy, Law and the FDA Role in Regulation In Encyclopedia of Ethical, Legal, and Policy Issues in Biotechnology, ed. Thomas J. Murray Maxwell J. Mehlman. New York : Wiley.
37. Miwa, Yoshiro J. Mark Ramseyer. 2005 Toward a Theory of Jurisdictional Competition: The Case of the Japanese FTC Journal of Competition Law and Economics 1 (2 247 277.
38. Moe, Terry M. 1982 Regulatory Performance and Presidential Administration American Journal of Political Science 26 : 197 224.
39. Moe, Terry M. 1985 Control and Feedback in Economic Regulation: The Case of the NLRB American Political Science Review 79 : 1094 1116.
40. Moe, Terry M. 1989 The Politics of Bureaucratic Structure In Can the Government Govern? ed. J. E. Chubb P. E. Peterson. Washington, DC : The Brookings Institutions.
41. National Bioethics Advisory Commission (NBAC). 1997. Cloning Human Beings. Rockville, MD : U.S. Government Printing Office.
42. Nightingale, Stuart. 1991 Special Issue: The Regulation of Human Tissue and Organs Food, Drug, Cosmetic Law Journal 4 : 4 7.
43. Pierson, Paul. 2004. Politics in Time: History, Institutions and Social Analysis. Princeton, NJ : Princeton University Press.
44. Pollitt, Christopher. 2008. Time, Policy and the Past: Governing with the Past. Oxford, UK : Oxford University Press.
45. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. 1982. Splicing Life: The Social and Ethical Issues of Genetic Engineering with Human Beings. Washington, DC : U.S. Government Printing Office.
46. Price, Elizabeth C. 1998 Does FDA Have Authority to Regulate Human Cloning? Harvard Journal of Law and Technology 11 (3 619 641.
47. Quirk, Paul. 1980 The Food and Drug Administration In The Politics of Regulation, ed. James Q. Wilson. New York : Basic Books.
48. Rainsbury, Joseph M. 2000 Biotechnology on the RAC-FDA/NIH Regulation of Human Gene Therapy Food and Drug Law Journal 55 : 575 600.
49. Riley, Margaret Foster Richard A. Merrill. 2005 Regulating Productive Genetics: A Review of American Bioethics Commission and Comparison to the British Human Fertilization and Embryology Authority Columbia Science and Technology Law Review 6 : 1 64.
50. Rokosz, Gregory J. 2000 Human Cloning: Is the Search of FDA Authority Too Far a Stretch? Seton Hall Law Review 30 : 464 512.
51. Ruef, Martin Richard W. Scott. 1998 A Multidimensional Model of Organizational Legitimacy: Hospital Survival in Changing Institutional Environments Administrative Science Quarterly 43 (4 877 904.
52. Scharpf, Fritz W. 1997. Games Real Actors Play: Actor-Centered Institutionalism in Policy Research. Boulder, CO : Westview Press.
53. Sheingate, Adam D. 2006 Promotion versus Precaution: The Evolution of Biotechnology Policy in the United States British Journal of Political Science 36 : 243 268.
54. Silberner, Joanne. 1998 Capital Report: Seeding the Cloning Debate Hasting Center Report 28 (2 5.
55. Spence, David B. 1997 Agency Policy Making and Political Control: Modeling Away the Delegation Problem Journal of Public Administration Research and Theory 2 : 199 219.
56. Sunstein, Cass R. 1998 Is Tobacco a Drug: Administrative Agencies as Common Law Courts Duke Law Review 47 : 1013 1069.
57. Ting, Michael M. 2002 A Theory of Jurisdictional Assignments in Bureaucracies American Journal of Political Science 46 (2 364 378.
58. Ting, Michael M. 2009 Organizational Capacity Journal of Law, Economics and Organization. 〈 http://jleo.oxfordjournals.org/cgi/reprint/ewp021v1 〉. (November 13, 2009).
59. U.S. Food, and Drug Administration (FDA). 2003 Analyte Specific Reagents; Small Entity Compliance; Guidance for Industry Document issued by the Center for Devices and Radiological Health on February 26. 〈 http://www.hpm.com/ pdf/FDA2003homebrewguidance.pdf 〉. (November 13, 2009).
60. U.S. Government Accounting Office (GAO). 2006a CMS and Survey Organization Oversight Is Not Sufficient to Ensure Lab Quality Testimony Before the Subcommittee on Criminal Justice, Drug Policy and Human Resources, Committee on Government Reform, House of Representatives, June 27.
61. U.S. Government Accounting Office (GAO). 2006b Nutrigenetic Testing: Tests Purchased from Four Web Sites Misled Consumers Testimony Before the Special Committee on Aging, U.S. Senate, 27, July 9.
62. Weingarten, Gina. 1998 Strange Egg Washington Post, January 25: F1.
63. Weingast, Barry R. 1984 The Congressional-Bureaucratic System: A Principal-Agent Perspective (with application to the SEC) Public Choice 44 (2 147 191.
64. Weingast, Barry R. Mark J. Moran. 1983 Bureaucratic Discretion or Congressional Control? Regulatory Policymaking by the Federal Trade Commission Journal of Political Economy 91 : 756 800.
65. Wilson, James Q. 1989. Bureaucracy: What Government Agencies Do and Why They Do It. New York : Basic Books.